Seeking Volunteers
The following is a list of current research studies that are seeking volunteers. Although Erowid attempts to screen out bogus or extremely poorly designed research, inclusion here does not suggest that the research is endorsed by Erowid.
Before deciding to participate in any research project read accompanying information carefully. Check whether the research is sponsored by a university or some organization you trust not to misuse the information you provide. See if they have clear privacy statements and whether the research protocol has been reviewed by an Institutional Review Board (IRB).
Before deciding to participate in any research project read accompanying information carefully. Check whether the research is sponsored by a university or some organization you trust not to misuse the information you provide. See if they have clear privacy statements and whether the research protocol has been reviewed by an Institutional Review Board (IRB).
|
February 1, 2008 - March 14, 2008
Title of Study: Enhancement of the Opioid Attractiveness Scale #
Organization: Inflexxion, Inc.
Principal Investigator: Stephen Butler, Ph.D.
Other Investigators: Nathaniel Katz, M.D., M.S.
Approved by IRB: Yes (New England Institutional Review Board)
Type: Anonymous online questionnaire
Funded by: King Pharmaceuticals, Inc.
Location: Online
Paid Participation: No
Travel Expenses: N/A
Contact: Kathy Fernandez (617)614-0412 - painandopioid@inflexxion.com
Summary:
Inflexxion is conducting a research study to learn more about the features and characteristics of prescription opioids that make these drugs attractive to use recreationally. By doing so, we hope to enhance the Opioid Attractiveness Scale, a scale that measures the abuse potential of opioid medications. Click on the url above for additional information about the project and survey. |
|
November 1, 2007 to January 1, 2008
Brief GHB Survey #
Organization: California Poison Control System
Principal Investigator: Dr. Jo Dyer
Other Investigators: Dr. Ilene Anderson and Dr. Susan Kim
Approved by IRB: Yes (UCSF)
Type: Anonymous online questionnaire
Funded by: NIDA grant DA14935
Location: Online
Paid Participation: No
Travel Expenses: N/A
Contact: Dr. Jo Dyer, Dr. Ilene Anderson or Dr. Susan Kim at 415-502-6042
Summary:
This is a research study investigating the changing patterns of GHB (gamma hydroxybutyrate) use and factors that may influence these patterns. Dr. Jo Dyer, PharmD and the FORGE study group, with the California Poison Control System and the University of California San Francisco, are conducting research on GHB. |
|
April 16, 2004 – December 2007
A Human Phase II Study - Safety and Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in the Treatment of Chronic Posttraumatic Stress Disorder
Organization: MAPS
Principal Investigator: Michael Mithoefer, MD
Other Investigators: Ann Mithoefer BSN, Mark T.
Wagner PhD
Approved by IRB: No IRB listed, FDA-accepted
Type: Clinical Study
Location: Charleston, SC
Paid Participation: No
Travel Expenses: Yes
Contact: Ann Mithoefer BSN or Michael Mithoefer, MD. Please call (843) 849-6899
Summary:
This study seeks men and women without high blood pressure or heart disease, ages 18-70, and diagnosed with PTSD from being a crime victim (sexual or physical assault, for example) or from war-related experience (from five years ago or less), who still have symptoms despite treatment with psychotherapy and medication. |
Other sites that link to research: